IP Group

IP Group plc is a London Stock Exchange-listed investor (ticker: IPO) founded in 2001 that specializes in backing and growing early-stage science and technology companies, primarily university spin-outs. Headquartered in London with operations in Melbourne, Australia, IP Group invests from its own balance sheet across three thematic areas—HealthTech, DeepTech, and CleanTech—from seed and incubation stages through to growth and maturity. The firm reported a net asset value of £975.1 million at year-end 2025, with gross cash of £211 million, and has supported over 600 companies since inception. IP Group maintains deep partnerships with leading research institutions including the University of Oxford, University of Cambridge, and Imperial College London, and extends its reach to Australia through partnerships with the Group of Eight universities. Through its subsidiary Parkwalk, the UK's largest growth EIS fund manager with approximately £557 million in third-party assets under management, IP Group also channels additional capital to its portfolio companies. Notable portfolio companies have included Oxford Nanopore Technologies, Hinge Health, and First Light Fusion.